Navigation Links
Data on Avicena's Drug Candidate HD-02 Presented at the 2007 World Congress on Huntington's Disease
Date:11/19/2007

se III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

SAFE HARBOR

This release contains forward-looking statements that reflect, among other things, management's current expectations, plans and strategies, all of which are subject to known and unknown risks, uncertainties and factors that may cause our actual results to differ materially from those expressed or implied by these forward-looking statements. Many of these risks are beyond our ability to control or predict. See "Risk Factors" under "Item 6. Management's Discussion and Analysis of Financial Condition and Results of Operation" from our Annual Report on Form 10-KSB for the year ended December 31, 2006, and other descriptions in the Company's public filings with the Securities and Exchange Commission for a discussion of such risks, including the Company's need for additional funds, the Company's dependence on a limited number of therapeutic compounds, the stage of the products the Company is developing, uncertainties relating to clinical trials and regulatory reviews, competition and dependence on collaborative partners, the Company's ability to avoid infringement of the patent rights of others, and the Company's ability to obtain adequate patent protection and to enforce these rights. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Avicena does not undertake any obligation to update or review any such forward-looking information, whether as a result of new information, future events or otherwise.

Contact:

The R
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Some Epilepsy Patients Are Good Candidates for Surgery
2. Presidential Candidates Address Health, Financial Security at AARPs Life@50+
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. U.S. Physicians Question Presidential Candidates
5. Schizophrenia candidate genes affect even healthy individuals
6. Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement
7. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
8. Poll Shows Voters Want Long Term Care Included in Presidential Candidates Healthcare Proposals, Released at 2007 National Long Term Care Symposium
9. 1 in 5 bariatric surgery candidates not psychologically cleared for surgery
10. Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates
11. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Dalla, TX (PRWEB) May 19, 2013 ... comprehensive analysis for US, UK, Spain, Japan, Italy, ... pertaining to the molecular diagnostics laboratory practice, as ... technological trends with significant market impact during the ... of DNA probe and biochip technologies, test formats, ...
(Date:5/19/2013)... NY (PRWEB) May 19, 2013 Americans ... According to the newest American Veterinary Medical Association (AVMA) ... of American dog owners consider their dog a member ... who had said as much five years earlier. , ... dollar value of the national income dedicated to pets ...
(Date:5/19/2013)... 19, 2013 Vegas Hotel Escapes, the ... to announce the launch it's all new vacation packages ... Grand on 5/19/2013. Consumers traveling to Las Vegas will ... available on VegasHotelEscapes.com's website. Travelers will be pleased to ... competitors price. , Vegas Hotel Escapes specializes in helping ...
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... Universal Capital,Management, Inc. (OTC Bulletin Board: UCMT.OB), ... management and strategic growth,resources to emerging growth ... of its,holdings, iVolution Medical Systems, Inc. will ... to fruition. , ...
... Schizophrenia could be caused by faulty signalling in the ... journal Molecular Psychiatry . In the biggest study ... samples donated by people with the condition have identified ... schizophrenia patients compared to controls. , Many of these ...
... Company, Inc.,s new ,Feel Good, Light Lenses are perfect decorating pieces ... economical time. , ... (PRWEB) March 3, 2009 -- ... nation, the Flag Company, Inc. recently launched ,Feel Good, Light Lenses ...
... Bingo tickets for the Cystic Fibrosis Trust and raised over £10,000 for ... ... -- JackpotCity.com Online Bingo has ensured that both the Cystic Fibrosis Trust ... fight against this life-threatening disease. , , , , ,For over 40 ...
... Guinea The southeast Pacific nation of Papua ... diverse ecosystems on Earth, has created its first national ... tropical forest larger than Singapore. , The decision by ... local communities neighboring the newly established YUS Conservation Area, ...
... the flu vaccine and flu vaccine supplies has unveiled their annual 2009 ... , ... (Vocus) March 2, 2009 -- Nationwide Medical/Surgical , a distributor ... 2009 list of what to do if exposed to the flu virus., ...
Cached Medicine News:Health News:iVolution Medical Systems to Assist Healthcare Providers With Compliance of President Obama's Stimulus Plan 2Health News:iVolution Medical Systems to Assist Healthcare Providers With Compliance of President Obama's Stimulus Plan 3Health News:Schizophrenia linked to signaling problems in new brain study 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:JackpotCity.com Online Bingo Raises Over 10,000 for Cystic Fibrosis Trust 2Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4Health News:Nationwide Medical/Surgical Reveals Their Help Sheet For Those Infected with Influenza Virus 2
(Date:5/17/2013)... , May 17, 2013  Serving a region of 650,000 ... , Caribbean Imaging and Radiation Therapy (CIRT, ... capabilities with the acquisition of an Elekta Versa HD™ system, ... HD offers clinicians the versatility to deliver conventional therapies to ... also enabling treatment of highly complex cancers that require extreme ...
(Date:5/17/2013)... N.J. , May 17, 2013  PENTAX ... and Hitachi-Aloka Medical, a global leader in ultrasound ... two global companies to enable further innovation in ... years, the Hitachi-Aloka ultrasound systems and PENTAX Medical ... most trusted families of EUS systems. This agreement ...
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... 2, 2011 Bionovo, Inc. (NASDAQ: BNVI ), ... safe and effective treatments for women,s health and cancer, today ... clinical trial of their lead drug candidate for postmenopausal symptoms, ... community at the 13th Annual World Congress on Menopause in ...
... 2011 / PRNewswire / -- Cadence Pharmaceuticals, ... focused on in-licensing, developing and commercializing proprietary products principally ... the company,s President and CEO Ted Schroeder will present ... at 1:30pm Eastern Time (10:30am Pacific Time) during the ...
Cached Medicine Technology:Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 2Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 3Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 4
... Facilitates grasping and implanting the ... and within the capsular bag without ... mm long jaws are placed in ... handle. Smooth, flat, cross action handle ...
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Puntenney curved forceps, curved, smooth 10 mm platforms....
Hatsis tying forceps, titanium, long thin tying platforms....
Medicine Products: